New Models | GenomeWeb

New Models

The US National Cancer Institute is phasing out its panel of 60 human cancer cell lines in favor of fresh models, Nature News reports.

That panel of 60 cell lines has been in use for a quarter of a century and has been used to screen more than 100,000 compounds. But, as Nature News adds, when these lines were created, researchers had a different view of cancer

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Such High Hopes

Cell Manufacturing

This Week in PNAS

This Week in Cell

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.